Jennewein Biotechnologie

Living the impossible

The Company at a Glance

Jennewein Biotechnologie, recently acquired by Chr. Hansen, is a science-based company in the field of industrial biotechnology. We specialize in the development of new processes for the identification, characterization and production of scarce, functional monosaccharides and oligosaccharides. Our main focus is the production of sugar molecules with attractive health benefits.

Human milk oligosaccharides (HMOs) represent one of our major fields of activity. These complex natural sugar molecules are found uniquely in human milk. Human milk oligosaccharides cannot be digested by humans and thus, do not provide calories. However, HMOs have various functional health benefits beyond the intake of calories. We have developed innovative processes for the production of HMOs and have built up production capacity over the last few years allowing us to supply these oligosaccharides as food ingredients.


Foundation of Jennewein Biotechnologie


Start production of L-Fucose


Start production of first human milk oligosaccharides


Cooperation with Pfizer Nutrition in field of human milk oligosaccharides (HMO)


Expansion of production and optimization of production processes for L-Fucose


Adoption of non-exclusive commercialization strategy for human milk oligosaccharides (HMO)


Enlargement of the portfolio of human milk oligosaccharides (HMO)


U.S. FDA GRAS status of 2'-Fucosyllactose (HMO) for the application in general nutrition


Start Norovirus development project


Start production of Salic-Acid / N-Acetylneuraminic Acid


Start commercial production of 2'-Fucosyllactose (HMO)


Financing of the expansion of the production capacities for 2'-Fucosyllactose (HMO) by the European Investment Bank (EIB)


Infant nutrition starts with 2‘-Fucosyllactose in the USA


Medical nutrition product with 2‘-Fucosyllactose starts in the USA


Novel food registration in Europe is approved

Jennewein Biotechnologie also specializes in the development of production processes and the production of functional monosaccharides, including the extremely rare sugars L-Fucose and Sialic acid (N‑acetylneuraminic acid). These saccharides are found in the human body in high concentration and are required for a healthy development and functioning of our body. The monosaccharides manufactured by Jennewein Biotechnologie are used primarily as active ingredients for pharmaceutical and cosmetic products as well as for therapeutic animal feed.

We aim to manufacture rare sugars with scientifically demonstrated functional benefits using our innovative and efficient production processes. Our mission is to improve the health and wellbeing of consumers through our products.